Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)

April 14, 2023 Business Services

NEW YORK, April 14, 2023 — Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical …
News
Press release

UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal

April 13, 2023 Business Services

Brussels (Belgium) 13 April 2023 – 07:00 AM (CET) – UCB, a global biopharmaceutical company, today announced that The Lancet Neurology …
News
Press release

Adaptyv Bio creates a new paradigm for protein engineering using generative AI, open-source software and synthetic biology

April 13, 2023 Business Services

Lausanne, Switzerland – 13th April 2023; AI tools like ChatGPT are revolutionizing how the world generates text, images and code. …
News
Press release

BioInnovation Institute & Science Prize for Innovation winners announced

April 13, 2023 Business Services

COPENHAGEN, Denmark, April 13, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, …
News
Press release

ANGLE plc (“the Company”) Pharma Services Contract with Crescendo Biologics

April 13, 2023 Business Services

ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce that it has signed a …
News
Press release

Transgene’s Board of Directors Proposes the Appointment of Carol Stuckley, MBA, as New Independent Director

April 13, 2023 Business Services

Strasbourg, France, April 12, 2023, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops …
Appointment

ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) ACCEPTED FOR USE WITHIN NHS SCOTLAND EARLIER IN THE TREATMENT PATHWAY FOR HER2-POSITIVE METASTATIC BREAST CANCER

April 12, 2023 Business Services

Daiichi Sankyo UK Limited and AstraZeneca UK Limited welcome the news that the Scottish Medicines Consortium (SMC) has accepted Enhertu®▼ …
News
Press release

Almirall, the first to assess wellbeing in a dermatology clinical study

April 12, 2023 Business Services

BARCELONA, Spain. April 12, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced the …
News
Press release

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

April 11, 2023 Business Services

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science …
News
Press release

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

April 11, 2023 Business Services

LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …
News
Press release

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

April 11, 2023 Business Services

Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …
News
Press release

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

April 6, 2023 Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …
News
Press release

Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.

April 5, 2023 Business Services

Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …
News
Press release

Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine

April 5, 2023 Business Services

  SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …
News
Press release

Syncona Appoints Roel Bulthuis as Managing Partner

April 5, 2023 Business Services

05 April 2023   Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025